Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform-Reference-Cited by-同舟云学术

Attacking Latent HIV with convertibleCAR-T Cells, a Highly Adaptable Killing Platform

Published:2019-10 Issue:4 Volume:179 Page:880-894.e10
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Herzig Eytan,Kim Kaman Chan,Packard Thomas A.,Vardi Noam,Schwarzer Roland,Gramatica Andrea,Deeks Steven G.,Williams Steven R.,Landgraf Kyle,Killeen Nigel,Martin David W.,Weinberger Leor S.,Greene Warner C.

Funder

SCOPE

amfAR Institute for HIV Cure Research

University of California San Francisco-Gladstone Institutes Center for AIDS Research

James B. Pendleton Charitable Trust

NIH

NIDCR

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference125 articles.

1. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy;Archin;Nature,2012

2. BET bromodomain inhibition as a novel strategy for reactivation of HIV-1;Banerjee;J. Leukoc. Biol.,2012

3. Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals;Bar-On;Nat. Med.,2018

4. Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells;Battivelli;eLife,2018

5. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA;Bauer;Science,1999

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Cure: How Far We Have Come?;Indian Journal of Microbiology;2024-08-13

2. CAR-T Therapy in HIV: Pioneering Advances and Navigating Challenges;Infectious Diseases & Immunity;2024-07-25

3. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques;2024-05-09

4. Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques;2024-05-09

5. The construction of modular universal chimeric antigen receptor T (MU-CAR-T) cells by covalent linkage of allogeneic T cells and various antibody fragments;Molecular Cancer;2024-03-11